FDA Investigator Richard H Penta

Richard H Penta has conducted inspections on 102 sites in 9 countries as of 03 Mar 2009. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
102
Last Inspection Date:
03 Mar 2009
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Belgium, Ireland, Switzerland, France, Italy, Germany, Denmark
FDA Investigators that have inspected at least one site in common with Richard H Penta:
Aimee Cunningham, PhD, Alan R Condon, Alberto A Viciedo, Alice C Silva, Alice Canty, Allison A Rodriguez, Almaris N Alonso, Amanda E Lewin, PhD, Amber G Wardwell, Amy C Jordan, Amy Devlin, PhD, Andre S Lamontagne, Andrew M Barlow, Angela E Glenn, Anissa M Cheung, Ann Marie Montemurro, Ann Marie Schofield, Anne E Carpenter, Anne Marie Dubrey, Anthony N Onianwa, Arie C Menachem, Ariel Cruz Figueroa, Arindam Dasgupta, PhD, Ashar P Parikh, Ashley M Whitehurst, Azza Talaat, Barbara G Swan, Barbara M Frazier, Bill Tacket, Jr, Bradley D Newsad, Brenda P King, Brentley S Collins, Brittany D Terhar, Brooke K Higgins, Bruce H Mccullough, Burnell M Henry, Camerson E Moore, Carl A Huffman, III, Carla C Cummins, Carla C Tuite, Carlos Chavez, Carol L Rehkopf, Carolyn Yong, PhD, Cassandra L Abellard, Cheryl A Clausen, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christopher Downey, PhD, Christopher M Elliott, Christopher T Middendorf, Concepcion Cruz, Jr, Constance Desimone, Courtney N Long, Cynthia Jim, CSO, Dale A Nyberg, Daniel J Grabicki, Daniel L Zheng, Darren S Brown, Daryl A Dewoskin, David P Vanhouten, David Perkins, Dawn M Braswell, Debra L Pagano, Dennis Cantellops Paite, Destry M Sillivan, Devaughn Edwards, Diane C Thibodeau, Diane L Raccasi, Diane M Prince, Dien N Nguyen, Dominic R Frasca, Dorothy W Lee, Douglas C Kovacs, Douglas S Joslin, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Ekaterina Allen, Elizabeth B Griffin, Ellen P Madigan, Emmanuel A Dimaano, Jr, Eric L Dong, BS, Eric Rothschild, Erin D Mccaffery, Felix Maldonado, Francis A Guidry, Frederick F Razzaghi, Gajendiran Mahadevan, PhD, Gale E Ryan, Gary J Hagan, Gene D Arcy, George M Ibrahim, George T Allen, Jr, Guerlain Ulysse, Gunther Boekhoudt, PhD, Haley H Seymour, Hasan A Irier, PhD, Herbert M Corbello, Hien Albright, Hugh M Mcclure, II, Ivis L Negron, Jack Ragheb, Jacqueline Mdiaz Albertini, James C Maclaughlin, James Norman, James P Mcreavey, Jason A Rossi, Jawaid Hamid, Jay M Patria, Jean Lhu Primmer, Jee Chung, PhD, Jeffrey J Ebersole, Jennifer Lalama, Jianming Li, Joan A Loreng, Joanne Heim, John P Mistler, John S Hartford, John Stansberry, PhD, Jonathan G Matrisciano, Jose Acruz Gonzalez, Joseph H Procopio, Jr, Joyce A Rockwell, Julie A Finegan, Julie D Bringger, Justine M Corson, Kalavati Suvarna, PhD, Kara A Scheibner, PhD, Karen A Briggs, Karen E D'orazio, Karen Mcnabb Noon, Karen Takahashi, Kathleen E Mcafoose, Kathleen R Jones, PhD, Kathryn E Ogger, Keith M Reilly, Kelli F Dobilas, Kellia N Hicks, Kenneth H Williams, Kent A Conforti, Kent C Faul, Kham Phommachanh, Kim Lthomas Cruse, Kristina J Donohue, Lata C Mathew, PhD, Laurel A Beer, Lauren M Lawrance, Laurie B Frazier, LCDR Chad N Thompson, LCDR Debra Emerson, Leanna M Slarsky, Leo B Zadecky, Lewis K Antwi, Li Li, Lori M Newman, Luis A Dasta, Marcus F Yambot, Margaret E Walsh, Margaret M Sands, Marie F Morin, Marilyn Welchenbach, Mark C Lookabaugh, Mark R Mcclain, Marshalette O Edwards, Martha T Olone, Martin J Guardia, Mary Jeanet Mcgarry, Matthew C Watson, Matthew D Silverman, Matthew R Sleeter, Maxwell Van Tassell, PhD, Maya M Davis, Megan A Haggerty, Melissa J Garcia, Meredith L Miller, Meredith P Soehl, Investigator, Michael D Omeara, Michael J Casey, Michael J Nerz, Michael O Idowu, Michael P Sheehan, Michele L Obert, Michele Perry Williams, Michelle M Noe Varga, Michelle Yclark Stuart, Mihaly S Ligmond, Minh D Phan, Monique C Lo, Mra Davism, Mra Mcculloughj, Mra Narulaa, Mra V Millarw, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nailing Zhang, Nancy G Schmidt, Nancy L Neiger, Nealie C Newberger, Nicholas L Paulin, Nichole B Murphy, Nicole E Knowlton, Niketa Patel, Norman Wong, Ogechi C Nna, Omotunde O Osunsanmi, Paige R Mccoy, Pamela L Lee, Pamela L Ogonowski, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia A Mcilroy, Patrick C Klotzbuecher, Paul M Kawamoto, Paul P Geraci, Paula A Trost, Paula M Laplant, Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Priscilla M Pastrana, Rachael A Moliver, Rafael Nevarez Nieves, Ramon E Martinez, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Richard B Mcaroy, Richard L Friedman, Richard W Thornton, Robert D Tollefsen, Robert J Martin, Robert Jennings, Robert M Barbosa, Robert O'brian, Rory K Geyer, Rose Ashley, Ruben C Ayala, PharmD, Sandra P White, Sarah E Mcmullen, Satheesh Thomas, Scott T Ballard, Sean R Marcsisin, Seth A Mailhot, Shafiq S Ahadi, Simone E Pitts, Sixto M Mercado Rios, Slater K Bartlett, Stacey S Degarmo, Stacie A Woods, Stephen R Souza, Steven A Gonzales, Steven D Kehoe, Sunita Pandey, Susan F Laska, MS, Susan Kirshner, Susan P Bruederle, Susanne M Richardson, MS RAC, Suzanne M Healy, Sylvia A Craven, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Terrig Thomas, PhD, Terry C Kimball, Thomas J Arista, Thomas W Gordon, Thomas W Nerney, Tiffani D Wilson, Timothy M Glod, Torrance J Slayton, Tracey L Harris, Unnee Ranjan, Uttaniti Limchumroon (Tom), Victor J Gangi, Walden H Lee, Walter N Lange, Wayne E Seifert, Weston K Szymanski, William J Leonard, Xiao Hong Chen, Yanming An, PhD, Yasamin Ameri, Ying Xin Fan, PhD, Youmin Wang, Yumi J Hiramine, Yvette I Henry, Yvette I Johnson, Yvonne E Lozano, Yvonne Y Wu, Zachary L Miller

Richard H Penta's Documents

Publish Date Document Type Title
August, 2008 FDA 483 Ameridose, LLC - Form 483, 2008-08-06
May, 2001 EIR Johnson Matthey Pharmaceuticals Materials - EIR, 2001-06-11
May, 2008 FDA 483 Armstrong Pharmaceuticals, Inc. - Form 483, 2008-05-13
August, 2006 FDA 483 AstraZeneca LP - Form 483, 2006-08-23
December, 2002 FDA 483 Response OPK Biotech, LLC - Form 483R, 2003-04-22
July, 2000 FDA 483 Response Janssen - Cilag S.p.A. - Form 483R, 2000-07-31
April, 2000 EIR AMAG Pharmaceuticals, Inc. - EIR, 2000-04-20
February, 2007 FDA 483 Pharmasol Corporation - Form 483, 2007-02-08
July, 2000 EIR Janssen - Cilag S.p.A. - EIR, 2005-05-18
May, 2001 FDA 483 Response Scherer, R.P. - Form 483R, 2001-06-06
December, 2002 FDA 483 Response OPK Biotech, LLC - Form 483R, 2002-12-10
June, 2002 EIR Holistic Family and Pets - EIR, 2002-06-25
May, 2001 FDA 483 SCHERER DRUG DELIVERY SYSTEMS - Form 483, 2001-05-24
September, 2008 FDA 483 Vericel Corporation - Form 483, 2008-09-19
July, 2000 FDA 483 Janssen - Cilag S.p.A. - Form 483, 2000-07-06
December, 2002 EIR OPK Biotech, LLC - EIR, 2002-12-18
November, 2007 FDA 483 Paragon Marketing Global, Inc. - Form 483, 2007-11-06
March, 2005 EIR Braintree Laboratories, Inc. - EIR, 2005-03-03
May, 2008 EIR Armstrong Pharmaceuticals, Inc. - EIR, 2008-05-13
December, 2002 EIR OPK Biotech, LLC - EIR, 2002-11-14
August, 2008 FDA 483 Response Ameridose, LLC - Form 483R, 2008-08-22
January, 2006 FDA 483 Tedor Pharma Inc. - Form 483, 2006-01-20
December, 2003 EIR AstraZeneca LP - EIR, 2003-12-17
July, 2000 FDA 483 GRUNENTHAL GMBH - Form 483, 2000-07-12
October, 2004 FDA 483 Ivax Pharmaceuticals Inc - Form 483, 2004-10-21
December, 2002 FDA 483 OPK Biotech, LLC - Form 483, 2002-11-22
July, 2000 EIR Grunenthal GmbH - EIR, 2000-07-12
December, 2008 FDA 483 Genzyme Corporation - Form 483, 2008-12-05
December, 2002 FDA 483 OPK Biotech, LLC - Form 483, 2002-12-18
April, 2003 EIR Cambridge Isotope Laboratories, Inc. - EIR, 2003-04-02
May, 2001 EIR Scherer, R.P. - EIR, 2001-06-19
May, 2001 FDA 483 Johnson Matthey Pharmaceuticals Materials - Form 483, 2001-05-11
October, 2000 FDA 483 Dartmouth Pharmaceuticals Inc. - Form 483, 2000-10-10
January, 2003 FDA 483 Genzyme Corporation - Form 483, 2003-01-31
May, 2000 FDA 483 Clinical Science Laboratories, Inc. - Form 483, 2000-05-08
October, 2004 EIR Ivax Pharmaceuticals Inc - EIR, 2004-10-21
August, 2008 EIR Ameridose, LLC - EIR, 2008-08-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more